All over the body are tiny sensors called nociceptors whose job is to spot potentially harmful stimuli and send warning ...

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for ...

Use of liraglutide or semaglutide therapy does not increase risk for thyroid cancer among patients with type 2 diabetes or obesity.

Psilocybin—the psychedelic compound that occurs naturally in certain "magic" mushroom species—has been shown in trials to ...

Kanazawa University, in collaboration with Osaka University and the National Institutes for Quantum Science and Technology, ...

For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major ...

In a study published in Nature Immunology on January 6, a research team led by Prof. Qian Youcun from the Shanghai Institute ...

More than one-quarter of adults aged 25 to 64 years from 99 countries are eligible to receive a GLP-1 receptor agonist.

Researchers uncover a hidden nanoscale mechanism critical for Met receptor activation, providing a new blueprint for targeted ...

Among adolescents with asthma and overweight or obesity, the relative risk for acute asthma exacerbations was significantly reduced with GLP-1 receptor agonist use vs. nonpharmacological weight ...